Jaume Capdevila, Medical Oncologist at Vall d’Hebron University Hospital, shared a post on X:
“Have you seen neuroendocrine cancer oral patients at Developmental Therapautics ASCO25? Slowly but progressive relevance of Neuroendocrine Neoplasms in early drug oncological research, Don’t miss the opportunity for great discussion with Thor Halfdanarson and Heloisa Soares.”